Cargando…
Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-der...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376005/ https://www.ncbi.nlm.nih.gov/pubmed/35974872 http://dx.doi.org/10.2147/IJN.S362244 |
_version_ | 1784768070962642944 |
---|---|
author | Chen, Tingting Ma, Bingxiang Lu, Shi Zeng, Lupeng Wang, Huaying Shi, Wanhua Zhou, Linying Xia, Yaokun Zhang, Xi Zhang, Jing Chen, Jinghua |
author_facet | Chen, Tingting Ma, Bingxiang Lu, Shi Zeng, Lupeng Wang, Huaying Shi, Wanhua Zhou, Linying Xia, Yaokun Zhang, Xi Zhang, Jing Chen, Jinghua |
author_sort | Chen, Tingting |
collection | PubMed |
description | PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-derived nanovesicles (CDNVs) at high yield and low cost by simple juicing and ultracentrifugation. The anticancer effects of CDNVs were evaluated in vitro and in vivo. METHODS: Transmission electron microscope, nanoparticle tracking analysis and laser particle size analysis were used to characterize the morphology, diameter and zeta potential of CDNVs, respectively. The anticancer effects of CDNVs in vitro were evaluated by MTT and apoptosis assays. The mechanism was further explored by measuring the protein levels of signal transducer and activator of transcription 3 pathway, reactive oxygen species, cell cycle distribution and caspase activity. In-vivo anticancer efficacy was evaluated by measuring tumor volume and weight of mice in three different treatment groups (CDNVs, cucurbitacin B and PBS). RESULTS: CDNVs inhibited proliferation of human non-small cell lung cancer cells by suppressing signal transducer and activator of transcription 3 activation, generating reactive oxygen species, promoting cell cycle arrest, and activating the caspase pathway. These CDNVs exhibited strong anticancer effects both in vitro and in vivo, and reduced the rate of tumor growth without obvious toxicity to mouse visceral organs. Compared with an equivalent dose of cucurbitacin B, CDNVs exerted stronger anticancer effects in vitro and in vivo. CONCLUSION: These results demonstrate that CDNVs suppress tumor growth. This study addresses the development of cancer therapeutic drugs using plant-derived nanovesicles that are cost-efficient, simple to produce in high yields, and provide an alternative approach to drug isolation that may help advance sustainability of medicinal plants. |
format | Online Article Text |
id | pubmed-9376005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93760052022-08-15 Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy Chen, Tingting Ma, Bingxiang Lu, Shi Zeng, Lupeng Wang, Huaying Shi, Wanhua Zhou, Linying Xia, Yaokun Zhang, Xi Zhang, Jing Chen, Jinghua Int J Nanomedicine Original Research PURPOSE: In recent years, a variety of nanoparticles with excellent anticancer and delivery properties have emerged for cancer therapy. However, potential toxicity, high production cost and complex preparation procedures have been obstacles to their use in biomedicine. Here, we obtained cucumber-derived nanovesicles (CDNVs) at high yield and low cost by simple juicing and ultracentrifugation. The anticancer effects of CDNVs were evaluated in vitro and in vivo. METHODS: Transmission electron microscope, nanoparticle tracking analysis and laser particle size analysis were used to characterize the morphology, diameter and zeta potential of CDNVs, respectively. The anticancer effects of CDNVs in vitro were evaluated by MTT and apoptosis assays. The mechanism was further explored by measuring the protein levels of signal transducer and activator of transcription 3 pathway, reactive oxygen species, cell cycle distribution and caspase activity. In-vivo anticancer efficacy was evaluated by measuring tumor volume and weight of mice in three different treatment groups (CDNVs, cucurbitacin B and PBS). RESULTS: CDNVs inhibited proliferation of human non-small cell lung cancer cells by suppressing signal transducer and activator of transcription 3 activation, generating reactive oxygen species, promoting cell cycle arrest, and activating the caspase pathway. These CDNVs exhibited strong anticancer effects both in vitro and in vivo, and reduced the rate of tumor growth without obvious toxicity to mouse visceral organs. Compared with an equivalent dose of cucurbitacin B, CDNVs exerted stronger anticancer effects in vitro and in vivo. CONCLUSION: These results demonstrate that CDNVs suppress tumor growth. This study addresses the development of cancer therapeutic drugs using plant-derived nanovesicles that are cost-efficient, simple to produce in high yields, and provide an alternative approach to drug isolation that may help advance sustainability of medicinal plants. Dove 2022-08-10 /pmc/articles/PMC9376005/ /pubmed/35974872 http://dx.doi.org/10.2147/IJN.S362244 Text en © 2022 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Chen, Tingting Ma, Bingxiang Lu, Shi Zeng, Lupeng Wang, Huaying Shi, Wanhua Zhou, Linying Xia, Yaokun Zhang, Xi Zhang, Jing Chen, Jinghua Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title | Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title_full | Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title_fullStr | Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title_full_unstemmed | Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title_short | Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy |
title_sort | cucumber-derived nanovesicles containing cucurbitacin b for non-small cell lung cancer therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376005/ https://www.ncbi.nlm.nih.gov/pubmed/35974872 http://dx.doi.org/10.2147/IJN.S362244 |
work_keys_str_mv | AT chentingting cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT mabingxiang cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT lushi cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT zenglupeng cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT wanghuaying cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT shiwanhua cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT zhoulinying cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT xiayaokun cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT zhangxi cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT zhangjing cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy AT chenjinghua cucumberderivednanovesiclescontainingcucurbitacinbfornonsmallcelllungcancertherapy |